Chronic obstructive pulmonary disease and cytokines

Critical Care Nursing Quarterly

Volumn 31, Issue 4, 2008, Pages 321-323

  Angerio, Allan D ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bronchitis; Chronic obstructive pulmonary disease; Emphysema; Inflammation; Interleukin; Transforming growth factor

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR ANTAGONIST; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE RECEPTOR; INTERLEUKIN DERIVATIVE;

ASTHMA; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; EMPHYSEMA; HEALTH EDUCATION; IMMUNOMODULATION; LUNG PARENCHYMA; NONHUMAN; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; REVIEW; TISSUE INJURY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; IMMUNOLOGY; INFLAMMATION; LEUKOCYTOSIS; LUNG ALVEOLUS MACROPHAGE; SMOKING;

HUMANS; INFLAMMATION; INTERLEUKINS; LEUKOCYTOSIS; MACROPHAGES, ALVEOLAR; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, CYTOKINE; SMOKING; TRANSFORMING GROWTH FACTOR BETA;

EID: 58149151437     PISSN: 08879303     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CNQ.0000336818.27418.cd     Document Type: Review

References (22)

1. Dinarello CA, Wolf SM. The role of interleukin-1 in disease. N Engl J Med. 1993;328:106-113.
2. Barnes PJ. Small airways in COPD. N Engl J Med. 2004;350:2635-2637.
3. Magne D, Palmer G, Barton JL, et al. The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes. Arthritis Res Ther. 2006;8(3):688- 692.
4. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J. 2001;18:50s- 59s.
5. British Thoracic Society. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax. 1997;52(suppl 5):S1- S28.
6. Borish L, Mascali JJ, Dishnck J, et al. Detection of alveolar macrophage-derived IL-1β in asthma. J Immunol. 1992;149:3078-3082.
7. Zeidel A, Beilin B, Yardeni I, et al. Immune response in asymptomatic smokers. Acta Anaesthesiol Scand. 2002;46:959-964.
8. Foronjy R, D'Armiento J. The role of collagenase in emphysema. Respir Res. 2001;2:348-352.
9. Zheng T, Zhu Z, Wang Z, et al. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J. Clin Invest. 2000;106:1081-1093.
10. Lappalainen U, Whitsett JA, Wert SE, et al. Interleukin-l beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol. 2005;32: 311-318.
11. Oven H, Erbay AR, Balci M, et al. Role of novel mediators of inflammation in left ventricular remodeling in patients with acute myocardial infarction: do they affect the outcome of patients? Angiology. 2007;58(1):45-54.
12. Wahl SM, Hunt DA, Wakefield LM, et al. Transforming growth factor type β induces monocyte chemo-taxis and growth factor production. Proc Natl Acad Sci USA. 1987;84:5788-5792.
13. 1 mediates mast cell chemotaxis. J Immunol. 1994;152:5860-5867.
14. Grashoff WF, Sont JK, Sterk PJ, et al. Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages. Am J Pathol. 1997;151:1785- 1790.
15. 1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158:1951-1957.
16. Rennard SJ. Inflammation and repair processes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:S12-S16.
17. Lu T, Tian L, Han Y, et al. Dose-dependent crosstalk between the transforming growth factor-β and interleukin-1 signaling pathways. Proc Natl Acad Sci USA. 2007;104:4365-4370.
18. Cote CG, Celli BR. New treatment strategies for COPD: pairing the new with the tried and true. Postgrad Med. 2005;117:27-34.
19. Lucey EC, Keane J, Kuang P-P, et al. Severity of elastase-induced emphysema is decreased in tumor necrosis factor-α and interleukin-1β receptor-deficient mice. Lab Invest. 2002;82:79-85.
20. DeBoer WI. Cytokines and therapy in COPD: a promising combination? Chest. 2002;121:209S- 218S.
21. DeBoer WI. Potential new drugs for therapy of chronic obstructive pulmonary disease. Expert Opin Invest Drugs. 2003;12(7):1067-1068.
22. Yamagata T, Ichinose M. Agents against cytokine synthesis or receptors. Eur J Pharmacol. 2006;533:289- 301.